Skip to main content

Bausch Lomb Corporation(BLCO-T)
TSX

Today's Change
Real-Time Last Update

Bausch Lomb Corporation

520 Applewood Crescent
Vaughan ON L4K 4B4 CAN
P: 905-695-7700
https://www.bausch.com

Sectors & Indices

Sector
Industry
Employees

Profile

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Key Executives

NameTitle
Information not available.